This study demonstrates that clioquinol and donepezil co‐encapsulated human serum albumin nanoparticles (dcHGT NPs) mitigate AD dysfunction to modulate Aβ‐related inflammation and neuronal damage. The gene discussed is ALB; the disease is Alzheimer disease.